Archives of Dermatological Research, Journal Year: 2025, Volume and Issue: 317(1)
Published: April 12, 2025
Language: Английский
Archives of Dermatological Research, Journal Year: 2025, Volume and Issue: 317(1)
Published: April 12, 2025
Language: Английский
Molecular Pharmaceutics, Journal Year: 2024, Volume and Issue: 21(5), P. 2118 - 2147
Published: April 25, 2024
The various kinds of nanocarriers (NCs) have been explored for the delivery therapeutics designed management skin manifestations. NCs are considered as one promising approaches attributable to sustained release and enhanced penetration. Despite extensive applications NCs, challenges in their via barrier (majorly stratum corneum) persisted. To overcome all associated with microneedle (MN) technology has emerged a beacon hope. Programmable drug release, being painless, its minimally invasive nature make it an intriguing strategy circumvent multiple systems. integration positive traits MNs boosts therapeutic effectiveness by evading corneum, facilitating through enhancing targeted delivery. This review discusses function skin, importance MNs, types superiority NC-loaded MNs. We highlighted NC-integrated ailments, combinational delivery, active targeting, vivo imaging, theranostics. clinical trials, patent portfolio, marketed products drug/NC-integrated covered. Finally, regulatory hurdles toward benchtop-to-bedside translation, along prospects needed scale up MN technology, deliberated. current is anticipated deliver thoughtful visions researchers, clinicians, formulation scientists successful development MN-technology-based product carefully optimizing variables.
Language: Английский
Citations
6Molecular Pharmaceutics, Journal Year: 2024, Volume and Issue: 21(9), P. 4450 - 4464
Published: Aug. 20, 2024
Microneedle (MN) patches are gaining increasing attention as a cost-effective technology for delivering drugs directly into the skin. In present study, two different 3D printing processes were utilized to produce coated MNs, namely, digital light processing (DLP) and semisolid extrusion (SSE). Donepezil (DN), cholinesterase inhibitor administered treatment of Alzheimer's disease, was incorporated coating material. Physiochemical characterization MNs confirmed successful incorporation donepezil well stability suitability materials transdermal delivery. Optical microscopy SEM studies validated uniform weight distribution precise dimensions MN arrays, while mechanical testing ensured MNs' robustness, ensuring efficient skin penetration. vitro conducted evaluate produced patches, indicating their potential use in clinical treatment. Permeation revealed significant increase DN permeation compared plain material, affirming effectiveness enhancing drug Confocal laser scanning (CLSM) elucidated API, within layers, demonstrating sustained release transcellular transport pathways. Finally, cell also on NIH3T3 fibroblasts biocompatibility safety printed objects applications.
Language: Английский
Citations
6Advanced Healthcare Materials, Journal Year: 2024, Volume and Issue: unknown
Published: June 12, 2024
Abstract Coated microneedles (CMNs) are a minimally invasive platform for immediate‐release transdermal drug delivery. However, the practical applications of CMNs have been significantly hindered by challenges associated with complex formulations, single function, and limited loading capacity. This study has developed spiderweb‐shaped iron‐coordinated polymeric nanowire network (Fe‐IDA NWs). The resulting Fe‐IDA NWs endowed certain viscosity due to synergy multiple supramolecular interactions. allows them replace traditional thickeners as microneedle coatings. NWs‐coated MNs) display rapid disintegration in skin model, which also enables swift diffusion their payloads into deeper layers. Additionally, MNs exhibit desirable enzymatic activity potential antibacterial ability. Thus, can enhance therapeutic efficacy against wound infection through synergistic effects, avoid overly complicated formulation release nontherapeutic molecules conventional CMNs. As proof‐of‐concept, loaded chlorin e6 showed chemodynamic‐photodynamic effect methicillin‐resistant Staphylococcus aureus‐infected model mice. Collectively, this work significant implications future CMNs‐based delivery systems expands application fields metal coordination polymer (MCP) materials.
Language: Английский
Citations
5International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 279, P. 134973 - 134973
Published: Aug. 24, 2024
Language: Английский
Citations
4International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 280, P. 135923 - 135923
Published: Sept. 23, 2024
Language: Английский
Citations
4Acta Pharmaceutica Sinica B, Journal Year: 2025, Volume and Issue: 15(2), P. 1126 - 1142
Published: Jan. 7, 2025
Recently, photodynamic therapy (PDT) has gained considerable attention as a promising therapeutic approach for the treatment of psoriasis. Unfortunately, activation high mobility group box 1 protein (HMGB1) by PDT triggers innate and adaptive immune responses, which exacerbate skin inflammation. Herein, we combined glycyrrhizic acid (GA), natural anti-inflammatory compound immunomodulator derived from herb Glycyrrhiza uralensis Fisch., with actuated photosensitizer chlorin e6 (Ce6) co-loading them in GA-based lipid nanoparticles coated catechol-modified quaternary chitosan salt (GC NPs/QCS-C). GC NPs/QCS-C exhibited drug loading efficacy, uniform size distribution, an ideal topical adhesive property, enhanced retention penetration psoriasis-like lesions, intracellular uptake epidermal cells compared counterparts. Subsequently, transdermal administration followed near-infrared laser radiation imiquimod-induced mouse model significantly ameliorated psoriasis symptoms, promoted apoptosis hyperproliferative cells, alleviated inflammatory cascade. The significant outcomes were attributed to synergistic effects GA on modulating cell recruitment inhibiting dendritic maturation. Our results demonstrated that bio-adhesive nanosystem combines Ce6 offers chemo-phototherapeutic strategy treatment.
Language: Английский
Citations
0Journal of Drug Delivery Science and Technology, Journal Year: 2025, Volume and Issue: 106, P. 106748 - 106748
Published: Feb. 22, 2025
Language: Английский
Citations
0International Journal of Pharmaceutics, Journal Year: 2025, Volume and Issue: unknown, P. 125385 - 125385
Published: Feb. 1, 2025
Language: Английский
Citations
0Journal of Drug Delivery Science and Technology, Journal Year: 2025, Volume and Issue: unknown, P. 106785 - 106785
Published: March 1, 2025
Language: Английский
Citations
0International Journal of Pharmaceutics, Journal Year: 2025, Volume and Issue: unknown, P. 125423 - 125423
Published: March 1, 2025
Language: Английский
Citations
0